Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)

NACompletedINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

December 20, 2020

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

Xpert HCV VL

Use of Cepheid GeneXpert HCV VL test as diagnostic tool to test for HCV RNA for diagnosis of hepatitis C infection, to test for sustained virological response at 12 weeks post treatment completion

Trial Locations (2)

Unknown

Myanmar Liver Foundation Than Sitt Charity Clinic, Yangon

Thingangyun Clinic, Yangon

All Listed Sponsors
collaborator

Myanmar Liver Foundation

OTHER

collaborator

Foundation for Innovative New Diagnostics, Switzerland

OTHER

collaborator

UNITAID

OTHER

lead

Macfarlane Burnet Institute for Medical Research and Public Health Ltd

OTHER

NCT03939013 - Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) | Biotech Hunter | Biotech Hunter